Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Artificial Intelligence-Based Virtual Reality on Patient With Upper Gastrointestinal Endoscopy (Virtual)

25. september 2026 opdateret af: Eman Abdelfatah Shokr, Al-Zaytoonah University of Jordan

Effect of Artificial Intelligence-Based Virtual Reality on Patient-Reported Outcomes During Upper Gastrointestinal Endoscopy: A Randomized Controlled Trial

This randomized controlled trial evaluates whether an artificial intelligence-based virtual reality (AI-VR) relaxation intervention can improve patient outcomes during upper gastrointestinal endoscopy. Patients undergoing elective upper gastrointestinal endoscopy will be randomly assigned in a 1:1 ratio to either an AI-VR intervention group or a routine-care control group. Participants in the intervention group will receive a 10-15-minute AI-VR relaxation session immediately before the endoscopy, while participants in the control group will receive routine care. The study will assess patients' anxiety, pain perception, physiological parameters, and satisfaction in relation to the endoscopy procedure. The findings will help determine whether AI-VR can improve patient comfort and the overall endoscopy experience.

Studieoversigt

Detaljeret beskrivelse

Upper gastrointestinal endoscopy is an important diagnostic and therapeutic procedure; however, patients may experience anxiety, pain, discomfort, and physiological changes before and during the procedure. These experiences may negatively affect patient comfort and satisfaction. This study was designed to evaluate the effect of an artificial intelligence-based virtual reality (AI-VR) relaxation intervention on patient-reported and physiological outcomes among patients undergoing elective upper gastrointestinal endoscopy.

This study uses a randomized controlled trial design. Eligible patients undergoing elective upper gastrointestinal endoscopy will be randomly assigned in a 1:1 ratio to either an intervention group or a routine-care control group. The intervention group will receive a 10-15-minute AI-VR relaxation session immediately before undergoing upper gastrointestinal endoscopy. The control group will receive routine care according to the usual clinical practice.

The AI-VR intervention is intended to provide a relaxation experience before the endoscopic procedure. Patient outcomes will be assessed using validated measures of anxiety and pain, together with physiological parameters and patient satisfaction. Anxiety will be assessed using the State-Trait Anxiety Inventory (STAI), pain perception will be assessed using the Visual Analog Scale (VAS), and patient satisfaction will be assessed using the Patient Satisfaction Questionnaire (PSQ). Physiological parameters will also be assessed at the prespecified assessment time points.

The primary purpose of the study is to determine whether the AI-VR intervention improves patient outcomes during upper gastrointestinal endoscopy compared with routine care. Outcomes of interest include anxiety level, pain perception, physiological responses, and patient satisfaction.

Randomization will be performed using a computer-generated random sequence. Allocation concealment will be maintained using sequentially numbered, opaque, sealed envelopes. Eligible participants will be enrolled after confirmation of eligibility and informed consent and will then be assigned to their respective study groups according to the concealed allocation sequence.

Data will be analyzed using IBM SPSS Statistics version 26.0. Appropriate statistical tests will be used to compare outcomes between the intervention and control groups and to examine relationships among anxiety, pain, satisfaction, and other study variables.

The study is intended to provide evidence regarding the potential role of AI-based virtual reality as a non-pharmacological intervention for reducing anxiety and discomfort and improving physiological responses and satisfaction among patients undergoing upper gastrointestinal endoscopy.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

500

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

      • Amman, Jordan, 00000
        • Al zaytoonah University

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 65 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria

Participants will be eligible for inclusion if they:

  1. Are within the prespecified age range for the study ([insert minimum and maximum age
  2. Are scheduled to undergo elective upper gastrointestinal endoscopy.
  3. Are able to understand the study procedures and communicate effectively.
  4. Are willing to participate in the study and provide informed consent.

Exclusion Criteria

Participants will be excluded if they:

  1. Have a condition that prevents them from safely participating in the virtual reality intervention.
  2. Have significant visual, auditory, cognitive, or neurological impairment that would interfere with the use of the virtual reality intervention or completion of the study assessments.
  3. Have previously participated in this study.
  4. Are unable or unwilling to provide informed consent.
  5. Require an urgent or emergency upper gastrointestinal endoscopy.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: AI-Based Virtual Reality Group

Artificial Intelligence-Based Virtual Reality Relaxation

Artificial Intelligence-Based Virtual Reality Relaxation

Ingen indgriben: Routine Care Control Group

non

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Patient Anxiety During Upper Gastrointestinal Endoscopy
Tidsramme: Anxiety (STAI) Baseline (pre-intervention) and immediately after the endoscopy procedure Pain intensity (VAS) Immediately after the endoscopy procedure Patient satisfaction (PSQ) Immediately after the endoscopy procedure Physiological parameters

Patient anxiety will be assessed using the State-Trait Anxiety Inventory (STAI). Anxiety scores will be compared between the artificial intelligence-based virtual reality intervention group and the routine-care control group to evaluate the effect of the intervention on patient anxiety during upper gastrointestinal endoscopy. The STAI consists of 20 items for assessing state anxiety, with total scores ranging from 20 to 80; higher scores indicate greater anxiety.

Anxiety (STAI) Baseline (pre-intervention) and immediately after the endoscopy procedure Pain intensity (VAS) Immediately after the endoscopy procedure Patient satisfaction (PSQ) Immediately after the endoscopy procedure Physiological parameters

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

4. januar 2026

Primær færdiggørelse (Faktiske)

5. januar 2026

Studieafslutning (Faktiske)

7. marts 2026

Datoer for studieregistrering

Først indsendt

21. september 2026

Først indsendt, der opfyldte QC-kriterier

25. september 2026

Først opslået (Faktiske)

29. september 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

29. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

25. september 2026

Sidst verificeret

1. september 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

Individual participant data will not be shared because the study did not establish a data-sharing arrangement for individual-level participant data. The data contain potentially identifiable participant information and will be retained securely by the research team in accordance with applicable ethical and institutional requirements. De-identified aggregate results will be reported in publications arising from the study.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner